Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Leadership development and bipartisan engagement remain central to advancing agriculture’s priorities in 2026.
This simple but powerful tool from Nutrien enables farmers to keep track of highly personalized input costs and expenses involved in running their operation.
Expanding chicken supplies are likely to keep prices under pressure in early 2026 despite steady demand growth.
Prompt removal of Christmas trees and careful handling of decorations reduce winter fire risk during an already high-demand season for emergency services.
Reduced winter placements indicate tighter fed cattle supplies and greater leverage during peak-demand months.
AFBF Economist: Farmer Bridge Assistance Payments Fall Short for Sugar, Alfalfa, and Specialty Crops
AFBF Economist Faith Parum provides analysis and perspective on the Farmer Bridge Assistance Program—what commodity growers should know and potential remedies for producers facing crop losses where that aid falls short.
